Pages that link to "Q41415663"
Jump to navigation
Jump to search
The following pages link to Induction of cyclin D1 overexpression by activated ras. (Q41415663):
Displaying 50 items.
- Arrest of G(1)-S progression by the p53-inducible gene PC3 is Rb dependent and relies on the inhibition of cyclin D1 transcription (Q24554293) (← links)
- Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1) (Q24685138) (← links)
- Cyclin D1 expression during rat mammary tumor development and its potential role in the resistance of the Copenhagen rat. (Q24791191) (← links)
- RAS oncogenes: weaving a tumorigenic web (Q28250360) (← links)
- BRAF mutation predicts sensitivity to MEK inhibition (Q29614281) (← links)
- Glycogen synthase kinase 3 has a limited role in cell cycle regulation of cyclin D1 levels (Q30478053) (← links)
- Cold-inducible RNA-binding protein bypasses replicative senescence in primary cells through extracellular signal-regulated kinase 1 and 2 activation (Q33401471) (← links)
- Glutamine deprivation induces abortive s-phase rescued by deoxyribonucleotides in k-ras transformed fibroblasts (Q33415058) (← links)
- Oncogenic ras-induced down-regulation of autophagy mediator Beclin-1 is required for malignant transformation of intestinal epithelial cells (Q33648384) (← links)
- Targeting protein prenylation for cancer therapy (Q33679239) (← links)
- Regulation of exit from quiescence by p27 and cyclin D1-CDK4. (Q33781529) (← links)
- KLF4 is regulated by RAS/RAF/MEK/ERK signaling through E2F1 and promotes melanoma cell growth (Q33809921) (← links)
- Melanoma: Stem cells, sun exposure and hallmarks for carcinogenesis, molecular concepts and future clinical implications (Q33822119) (← links)
- Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor (Q33888599) (← links)
- Non-transcriptional action of oestradiol and progestin triggers DNA synthesis. (Q33890864) (← links)
- Molecular pathways: targeting NRAS in melanoma and acute myelogenous leukemia (Q34052520) (← links)
- Murine coronavirus replication induces cell cycle arrest in G0/G1 phase. (Q34151707) (← links)
- Krüppel-like factor 5 mediates the transforming activity of oncogenic H-Ras (Q34312909) (← links)
- Regions and activities of simian virus 40 T antigen that cooperate with an activated ras oncogene in transforming primary rat embryo fibroblasts (Q34334235) (← links)
- Constitutive CCND1/CDK2 activity substitutes for p53 loss, or MYC or oncogenic RAS expression in the transformation of human mammary epithelial cells (Q34579889) (← links)
- Prediction of oncogenic interactions and cancer-related signaling networks based on network topology. (Q35035344) (← links)
- Cell cycle control mechanisms in B-1 and B-2 lymphoid subsets (Q35085510) (← links)
- Modulation of notch signaling elicits signature tumors and inhibits hras1-induced oncogenesis in the mouse mammary epithelium (Q35103047) (← links)
- Reduced skin tumor development in cyclin D1-deficient mice highlights the oncogenic ras pathway in vivo (Q35207717) (← links)
- Collateral expression of proangiogenic and tumorigenic properties in intestinal epithelial cell variants selected for resistance to anoikis (Q35250097) (← links)
- Oncogenic ras-induced down-regulation of pro-apoptotic protease caspase-2 is required for malignant transformation of intestinal epithelial cells (Q35604206) (← links)
- Absence of caveolin-1 sensitizes mouse skin to carcinogen-induced epidermal hyperplasia and tumor formation (Q35791457) (← links)
- Sequential activation of cyclin E and cyclin A gene expression by human papillomavirus type 16 E7 through sequences necessary for transformation (Q35848569) (← links)
- Drosophila cyclin D/Cdk4 regulates mitochondrial biogenesis and aging and sensitizes animals to hypoxic stress (Q35859986) (← links)
- Acquisition of anoikis resistance promotes the emergence of oncogenic K-ras mutations in colorectal cancer cells and stimulates their tumorigenicity in vivo (Q35925121) (← links)
- Impact of oncogenes in tumor angiogenesis: Mutant K- ras up-regulation of vascular endothelial growth factor/vascular permeability factor is necessary, but not sufficient for tumorigenicity of human colorectal carcinoma cells (Q36006469) (← links)
- Massive programmed cell death in intestinal epithelial cells induced by three-dimensional growth conditions: suppression by mutant c-H-ras oncogene expression (Q36236394) (← links)
- OCI-5/GPC3, a glypican encoded by a gene that is mutated in the Simpson-Golabi-Behmel overgrowth syndrome, induces apoptosis in a cell line-specific manner. (Q36255453) (← links)
- Activated Ras prevents downregulation of Bcl-X(L) triggered by detachment from the extracellular matrix. A mechanism of Ras-induced resistance to anoikis in intestinal epithelial cells (Q36328354) (← links)
- Ras transformation results in an elevated level of cyclin D1 and acceleration of G1 progression in NIH 3T3 cells (Q36552538) (← links)
- Induction of cell proliferation in quiescent NIH 3T3 cells by oncogenic c-Raf-1. (Q36568076) (← links)
- A Dominant-Negative Cyclin D1 Mutant Prevents Nuclear Import of Cyclin-Dependent Kinase 4 (CDK4) and Its Phosphorylation by CDK-Activating Kinase (Q36574144) (← links)
- Cyclin D1 expression in non-small-cell lung cancers: its association with altered p53 expression, cell proliferation and clinical outcome (Q36617988) (← links)
- Cyclin D1 overexpression perturbs DNA replication and induces replication-associated DNA double-strand breaks in acquired radioresistant cells (Q36724277) (← links)
- Expression of cyclin D1 in epithelial tissues of transgenic mice results in epidermal hyperproliferation and severe thymic hyperplasia (Q37429299) (← links)
- The role of cyclin D1 in response to long-term exposure to ionizing radiation (Q37505500) (← links)
- Reactive oxygen species-dependent signaling regulates cancer (Q37560671) (← links)
- Cyclin D1 in the Liver: Role of Noncanonical Signaling in Liver Steatosis and Hormone Regulation (Q37698862) (← links)
- Genetic Interactions of STAT3 and Anticancer Drug Development (Q38198930) (← links)
- Effects of RAL signal transduction in KRAS- and BRAF-mutated cells and prognostic potential of the RAL signature in colorectal cancer (Q38868595) (← links)
- Molecular-targeting therapies against quantitative abnormalities in gene expression with malignant tumors. (Q39126594) (← links)
- The radiation-sensitizing effect of flavopiridol in the esophageal cancer cell line Eca109. (Q39129076) (← links)
- The Strange Case of CDK4/6 Inhibitors: Mechanisms, Resistance, and Combination Strategies (Q39183079) (← links)
- Therapeutic Strategies for Targeting Ras Proteins (Q39262217) (← links)
- H-Ras increases release of sphingosine resulting in down-regulation of TSP-1 in non-transformed cells. (Q39392240) (← links)